Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Identification of early neurodegenerative pathways in progressive multiple sclerosis.

Journal article

Kaufmann M. et al, (2022), Nat Neurosci

Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).

Journal article

Dobson R. et al, (2022), Mult Scler Relat Disord, 63

Contemporary Neuroscience Core Curriculum for Medical Schools.

Journal article

Gelb DJ. et al, (2021), Neurology

Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships.

Journal article

Geraldes R. et al, (2020), Brain, 143, 2998 - 3012

Leading with inclusion during the COVID-19 pandemic: Stronger together.

Journal article

Warrior L. et al, (2020), Neurology, 95, 537 - 542

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis.

Journal article

Geraldes R. et al, (2020), J Neurol Neurosurg Psychiatry

Approach to the patient with neurologic disease


DE LUCA G. and Griggs R., (2019), Goldman-Cecil Medicine, 2-Volume Set

Sir Hugh Cairns: a pioneering collaborator.

Journal article

Attwood JE. et al, (2019), Acta Neurochir (Wien)

Multiple sclerosis and the risk of systemic venous thrombosis: A systematic review.

Conference paper

Ahmed O. et al, (2019), Mult Scler Relat Disord, 27, 424 - 430

Rapamycin in ischemic stroke: Old drug, new tricks?

Journal article

Hadley G. et al, (2018), J Cereb Blood Flow Metab

From Nose to Gut - The Role of the Microbiome in Neurological Disease.

Journal article

Bell JS. et al, (2018), Neuropathol Appl Neurobiol

Genes, smoking, and organic solvent exposure: An alarming cocktail for MS risk.

Journal article

Bell JS. and DeLuca GC., (2018), Neurology, 91, 199 - 200

Load More